EJNMMI Research

Papers
(The TQCC of EJNMMI Research is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Improving multi-pinhole CZT myocardial perfusion imaging specificity without changing sensibility by using adapted filter parameters39
[18F]F-FES PET for diagnosis, staging, and endocrine therapy prediction in ER-positive breast cancer: a systematic review and meta-analysis37
Unravelling physical and radiobiological effects of proton boron fusion reaction with anionic metallacarboranes ([o-COSAN]-) in breast cancer cells36
Preclinical evaluation of Affibody molecule for PET imaging of human pancreatic islets derived from stem cells30
Software compatibility analysis for quantitative measures of [18F]flutemetamol amyloid PET burden in mild cognitive impairment29
Short-time-window Patlak imaging using a population-based arterial input function and optimized Bayesian penalized likelihood reconstruction: a feasibility study28
Diagnostic models for fever of unknown origin based on 18F-FDG PET/CT: a prospective study in China27
Diagnostic accuracy of cerebral [18F]FDG PET in atypical parkinsonism26
Evaluation of damage discrimination in dopaminergic neurons using dopamine transporter PET tracer [18F]FECNT-d424
Establishing cutoff values for visual amyloid positivity in [18F]flutemetamol PET24
Assessment of hypoxia and oxidative-related changes in a lung-derived brain metastasis model by [64Cu][Cu(ATSM)] PET and proteomic studies23
Effect of radiation therapy on lymph node fluorescence in head and neck squamous cell carcinoma after intravenous injection of indocyanine green: a prospective evaluation23
Evaluation of the theranostic potential of [64Cu]CuCl2 in glioblastoma spheroids22
Correction: Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [11C]SMW139 and [18F]F-DPA21
Single time point quantitation of cerebral glucose metabolism by FDG-PET without arterial sampling21
The pons as an optimal background reference region for spinal 18F-FET PET/MRI evaluation21
Predictive value of 68[Ga]Ga-DOTA-TATE PET/CT volumetric parameters in assessing treatment response to long-acting somatostatin analogues in patients with well-differentiated neuroendocrine tumours20
Role of [18F]FAPI-04 in staging and therapeutic management of intrahepatic cholangiocarcinoma: prospective comparison with [18F]FDG PET/CT20
89Zr-labeled ImmunoPET targeting the cancer stem cell antigen CD133 using fully-human antibody constructs20
Brain 18 F-FDG PET reveals cortico-subcortical hypermetabolic dysfunction in juvenile neuropsychiatric systemic lupus erythematosus20
Radiosynthesis automation, non-human primate biodistribution and dosimetry of K+ channel tracer [11C]3MeO4AP19
[68Ga]Ga-FAPI versus 2-[18F]FDG PET/CT in patients with autoimmune thyroiditis: a case control study18
Imaging tumor and ascites-associated macrophages in a mouse model of metastatic ovarian cancer18
Light up heart-type fatty acid binding protein (FABP3) with a novel fluorine-18 labelled selective FABP3 ligand18
Retraction Note: Neuromelanin-targeted 18 F-P3BZA PET/MR imaging of the substantia nigra in rhesus macaques18
RETRACTED ARTICLE: Neuromelanin-targeted 18 F-P3BZA PET/MR imaging of the substantia nigra in rhesus macaques18
Feasibility of equivalent performance of 3D TOF [18F]-FDG PET/CT with reduced acquisition time using clinical and semiquantitative parameters17
18 F-Choline-PET/CT for non-FDG-avid salivary gland cancer: a preliminary report17
Biodistribution and dosimetry of the PET radioligand [18F]CHDI-650 in mice for detection of mutant huntingtin aggregates17
Impact of shortening time on diagnosis of 18F-florbetaben PET17
Post-reconstruction enhancement of [18F]FDG PET images with a convolutional neural network16
Prognostic value of baseline total metabolic tumour volume of 18F-FDG PET/CT imaging in patients with angioimmunoblastic T-cell lymphoma16
N-staging in large cell neuroendocrine carcinoma of the lung: diagnostic value of [18F]FDG PET/CT compared to the histopathology reference standard16
Intraoperative visualization of nerves using a myelin protein-zero specific fluorescent tracer15
[123I]MIBG is a better early marker of anthracycline cardiotoxicity than [18F]FDG: a preclinical SPECT/CT and simultaneous PET/MR study15
EANM recommendations based on systematic analysis of small animal radionuclide imaging in inflammatory musculoskeletal diseases14
Predicting the nature of pleural effusion in patients with lung adenocarcinoma based on 18F-FDG PET/CT14
In vitro proof of concept studies of radiotoxicity from Auger electron-emitter thallium-20114
Benefits and harms of implementing [18F]FDG-PET/CT for diagnosing recurrent breast cancer: a prospective clinical study13
There is a world beyond αvβ3-integrin: Multimeric ligands for imaging of the integrin subtypes αvβ6, αvβ8, αvβ3, and α5β1 by positron emission tomography13
A novel read methodology to evaluate the optimal dose of 68Ga-satoreotide trizoxetan as a PET imaging agent in patients with gastroenteropancreatic neuroendocrine tumours: a phase II clinical trial13
More fat, less migration: breast density as a predictor of sentinel lymph node non-visualization in breast cancer13
Comparison of nuclear imaging techniques and volumetric imaging for the prediction of postoperative mortality and liver failure in patients undergoing localized liver-directed treatments: a systematic13
Receptor depletion and recovery in small-intestinal neuroendocrine tumors and normal tissues after administration of a single intravenous dose of octreotide measured by 68Ga-DOTATOC PET/CT13
Radioimmunotherapy study of 131I-labeled Atezolizumab in preclinical models of colorectal cancer12
Comparison of 68Ga-PSMA PET/CT and multiparametric MRI for the detection of low- and intermediate-risk prostate cancer12
Biodistribution and dosimetry of the GluN2B-specific NMDA receptor PET radioligand (R)-[11C]Me-NB112
Change in brain amyloid load and cognition in patients with amnestic mild cognitive impairment: a 3-year follow-up study12
Initial evaluation of [18F]-FACBC for PET imaging of multiple myeloma12
Influence of corticosteroid treatment on CXCR4 expression in DLBCL11
Early prediction of treatment outcome for lenvatinib using 18F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma refractory to radioiodine treatment: a prospective, multicentre, n11
Optimal imaging time points considering accuracy and precision of Patlak linearization for 89Zr-immuno-PET: a simulation study11
Evaluation of [68 Ga]Ga-PSMA-I&T PET/CT with additional late scans of the pelvis in prostate-specific antigen recurrence using the PROMISE criteria11
Synthesis and preclinical evaluation of a novel fluorine-18 labeled small-molecule PET radiotracer for imaging of CXCR3 receptor in mouse models of atherosclerosis11
Glypican-3 targeted positron emission tomography detects sub-centimeter tumors in a xenograft model of hepatocellular carcinoma11
3D-printed dual holder system for simultaneous rat PET scanning: design and influence on quantification11
Spherization indices measured by resting SPECT improve risk stratification in patients with ischemia with non-obstructive coronary artery disease (INOCA)10
Correction: The association of DAT gene methylation with striatal DAT availability in healthy subjects10
Imaging pheochromocytoma in small animals: preclinical models to improve diagnosis and treatment10
Development of a minimally invasive simultaneous estimation method for quantifying translocator protein binding with [18F]FEPPA positron emission tomography10
APOE-ε4 modulates the association between regional amyloid deposition and cognitive performance in cognitively unimpaired middle-aged individuals10
Advancements in theranostic applications: exploring the role of fibroblast activation protein inhibition tracers in enhancing thyroid health assessment10
[68 Ga]Ga-FAPI-04 PET/CT may be a predictor for early treatment response in rheumatoid arthritis10
Radiomics predictive modeling from dual-time-point FDG PET Ki parametric maps: application to chemotherapy response in lymphoma10
An update on the use of image-derived input functions for human PET studies: new hopes or old illusions?9
Pharmacodynamics and biodistribution of [195mPt]cisplatin(CISSPECT®) in head and neck squamous cell carcinoma9
[18F]FDG PET/MRI enables early chemotherapy response prediction in pancreatic ductal adenocarcinoma9
Post-treatment three-dimensional voxel-based dosimetry after Yttrium-90 resin microsphere radioembolization in HCC9
Assessing the accuracy of [18F]PSMA-1007 PET/CT for primary staging of lymph node metastases in intermediate- and high-risk prostate cancer patients9
18F-FDG PET/CT-based deep learning radiomics predicts 5-years disease-free survival after failure to achieve pathologic complete response to neoadjuvant chemotherapy in breast cancer9
Prospective comparison of [18F]AlF-NOTA-octreotide PET/MRI to [68Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patients9
Combatting the effect of image reconstruction settings on lymphoma [18F]FDG PET metabolic tumor volume assessment using various segmentation methods9
Is there a diagnostic benefit of late-phase abdomino-pelvic PET/CT after urination as part of whole-body 68 Ga-PSMA-11 PET/CT for restaging patients with biochemical recurrence of prostate cancer afte9
Adenosine-induced splenic switch-off on [15O]H2O PET perfusion for the assessment of vascular vasodilatation9
Mid-treatment changes in intra-tumoural metabolic heterogeneity correlate to outcomes in oropharyngeal squamous cell carcinoma patients9
Impact of brain segmentation methods on regional metabolism quantification in 18F-FDG PET/MR analysis9
18F-FDG-PET/CT-based deep learning model for fully automated prediction of pathological grading for pancreatic ductal adenocarcinoma before surgery9
Deep learning and radiomics framework for PSMA-RADS classification of prostate cancer on PSMA PET9
[99mTc]Tc-Galacto-RGD2 integrin αvβ3-targeted imaging as a surrogate for molecular phenotyping in lung cancer: real-world data8
Lymphoscintigraphy findings in patients with chylothorax: influence of biochemical parameters8
Experimental study of early evaluation of radiosensitivity in mouse models of lung cancers using 89Zr-anti-γH2AX-TAT PET imaging8
Correction: PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer8
Comparative in vivo biodistribution of cells labelled with [89Zr]Zr-(oxinate)4 or [89Zr]Zr-DFO-NCS using PET8
The efficacy of short acquisition time using 18F-FDG total-body PET/CT for the identification of pediatric epileptic foci8
Drug characteristics derived from kinetic modeling: combined 11C-UCB-J human PET imaging with levetiracetam and brivaracetam occupancy of SV2A8
Preliminary mechanistic insights of a brain-penetrant microtubule imaging PET ligand in a tau-knockout mouse model8
Hypometabolism and atrophy patterns associated with Niemann-Pick type C8
Relationships between uptake of [68Ga]Ga-DOTA-TATE and absorbed dose in [177Lu]Lu-DOTA-TATE therapy8
Predicting the effect of different folate doses on [68Ga]Ga-PSMA-11 organ and tumor uptake using physiologically based pharmacokinetic modeling8
Myocardial glucose suppression may interfere with the detection of inflammatory cells with FDG-PET as suggested in a canine model of myocardial infarction8
CMR validation of left ventricular volumes and ejection fraction measured by the IQ-SPECT system in patients with small heart size8
Localization of TSH-secreting pituitary adenoma using 11C-methionine image subtraction8
Heart ketone metabolism under acute ketone supplementation in ZDF rats, a type 2 diabetes heart failure model8
Impact of administered amount of peptide on tumor dosimetry at the first cycle of peptide receptor radionuclide therapy (PRRT) in relation to total tumor somatostatin receptor expression8
In reply to Cheng et al. (DOI: 10.1186/s13550-023-00965-8)8
Altered brain metabolism in frontotemporal dementia and psychiatric disorders: involvement of the anterior cingulate cortex8
Visualizing GABA transporters in vivo: an overview of reported radioligands and future directions8
Validation of the C-X-C chemokine receptor 3 (CXCR3) as a target for PET imaging of T cell activation7
Effect of cerebral sinus venous thrombosis and its location on cerebral blood flow: a [15O]water PET study in acute stroke patients compared to healthy volunteers7
Baseline 18F-FDG PET/CT radiomics for prognosis prediction in diffuse large B cell lymphoma7
ParaPET: non-invasive deep learning method for direct parametric brain PET reconstruction using histoimages7
Automated extraction of the arterial input function from brain images for parametric PET studies7
Mitochondrial complex I density is associated with IQ and cognition in cognitively healthy adults: an in vivo [18F]BCPP-EF PET study7
Correction: Diagnostic and evaluative efficiency of 68Ga-FAPI-04 in skeletal muscle injury7
Synthesis and preclinical evaluation of [11C]EAI045 as a PET tracer for imaging tumors expressing mutated epidermal growth factor receptor7
Biological efficacy of simulated radiolabeled Lipiodol® ultra-fluid and microspheres for various beta emitters: study based on VX2 tumors7
Evaluating the biodistribution for [68Ga]Ga-PSMA-11 and [18F]F-PSMA-1007 PET/CT with an inter- and intrapatient based analysis7
The impact of introducing deep learning based [18F]FDG PET denoising on EORTC and PERCIST therapeutic response assessments in digital PET/CT7
Feasibility of safe outpatient treatment in pediatric patients following intraventricular radioimmunotherapy with 131I-omburtamab for leptomeningeal disease7
Evolution of dosimetric parameters through PRRT and potential impact on clinical practice: data from the prospective phase II LUMEN study7
First clinical experience with fractionated intracavitary radioimmunotherapy using [177Lu]Lu-6A10-Fab fragments in patients with glioblastoma: a pilot study7
Comparison of tracer kinetic models for 68Ga-PSMA-11 PET in intermediate-risk primary prostate cancer patients7
A histogram of [18F]BBPA PET imaging differentiates non-neoplastic lesions from malignant brain tumors7
Enhancing [177Lu]Lu-DOTA-TATE therapeutic efficacy in vitro by combining it with metronomic chemotherapeutics7
1.0320129394531